On Thursday, Terex Corporation (NYSE:TEX)’s shares declined -4.01% to $19.87.
Terex Corporation (TEX) declared that it has received the requisite consents with respect to its formerly declared consent solicitation from holders of its 6.00% Senior Notes due 2021 (the “2021 Notes”) and 6.50% Senior Notes due 2020 (the “2020 Notes” and together with the 2021 Notes, the “Notes”) to certain projected amendments to the indentures governing the Notes. The consent solicitation was conducted in connection with the formerly declared merger (the “Merger”) of Terex with Konecranes Plc, a Finnish public company limited by shares (“Konecranes”).
Having received the requisite consents for each series of Notes, Terex intends to promptly execute supplemental indentures covering the projected amendments to the indentures, as described in greater detail in the Consent Solicitation Notice (the “Notice”) formerly offered to holders of Notes. The terms of the supplemental indentures will not become operative unless and until the remaining conditions to the consent solicitation have been satisfied or waived.
In the event that each of the conditions to the consent solicitation described in the Notice is satisfied or waived, counting but not limited to consummation of the Merger, Terex will pay to each holder of record of Notes as of 5:00 p.m., New York City time, on August 26, 2015, who delivered a valid consent preceding to the Expiration Time, a cash fee of $17.50 for each $1,000 principal amount of 2021 Notes and $10.00 for each $1,000 principal amount of 2020 Notes consented to by such holder. Holders of Notes of any series who did not submit consents proceeding to the Expiration Time will not receive a consent fee, even if the projected amendments become operative with respect to such series of Notes. Subject to applicable law, the consent solicitation with respect to either series of Notes may be abandoned or terminated for any reason at any time, counting after the Expiration Time and preceding to the applicable projected amendments becoming operative, in which case the consents received with respect to such series of Notes will be voided and no consent fee will be paid to any holders with respect to such consents.
Terex Corporation operates as a lifting and material handling solutions company. Its Aerial Work Platforms segment designs, manufactures, services, and markets aerial work platform equipment, telehandlers, and light towers, in addition to related components and replacement parts under Terex and Genie names.
Scorpio Bulkers Inc (NYSE:SALT)’s shares gained 2.47% to $1.66.
Scorpio Bulkers Inc. ( SALT) (the “Company”) declared that Scorpio Services Holding Limited (“SSH”) has purchased an aggregate of 694,421 common shares of the Company at an average price of $1.62 share in the open market since the Company’s previous declarement on September 1, 2015. The Company presently has 336,227,302 common shares outstanding, of which SSH owns 20,036,403, or 6%.
Scorpio Bulkers Inc., together with its auxiliaries, engages in the marine transportation of dry bulk commodities. Its fleet transports a range of major and minor bulk commodities, counting ores, coal, grains, and fertilizers along worldwide shipping routes.
At the end of Thursday’s trade, Opko Health Inc. (NYSE:OPK)‘s shares surged 2.35% to $10.44.
OPKO Health, Inc. (OPK) declared a global license agreement with The Scripps Research Institute (TSRI) for the development and commercialization of novel lipoprotein signal peptidase (“Lsp”) inhibitors developed and discovered using a proprietary high throughput screening technology funded and exclusively licensed by OPKO from TSRI. OPKO has agreed to fund additional work in Dr. Wolan’s laboratory at TSRI and to move as rapidly as possible into clinical trials.
OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States and internationally. It operates through two segments, Pharmaceuticals and Diagnostics.
Lululemon Athletica inc. (NASDAQ:LULU), ended its Thursday’s trading session with -1.50% loss, and closed at $53.83.
lululemon athletica inc. (LULU) declared financial results for the second quarter ended August 2, 2015.
For the second quarter ended August 2, 2015:
- Net revenue for the quarter raised 16% to $453.0 million from $390.7 million in the second quarter of fiscal 2014.
- Total comparable sales, which comprises comparable store sales and direct to consumer, raised by 11% for the second quarter on a constant dollar basis.
- Comparable store sales for the second quarter raised by 6% on a constant dollar basis and direct to consumer revenue raised 35% on a constant dollar basis.
- Direct to consumer net revenue raised 30% to $82.2 million, or 18.2% of total Company revenue, in the second quarter of fiscal 2015, an enhance from 16.2% of total Company revenues in the second quarter of fiscal 2014.
The Company ended the second quarter of fiscal 2015 with $541.3 million in cash and cash equivalents contrast to $725.1 million at the end of the second quarter of fiscal 2014. Inventory at the end of the second quarter of fiscal 2015 totaled $280.6 million contrast to $180.5 million at the end of the second quarter of fiscal 2014. The Company ended the quarter with 336 stores.
lululemon athletica inc., together with its auxiliaries, designs, manufactures, and distributes athletic apparel and accessories for women, men, and female youth. It operates through two segments, Corporate-Owned Stores and Direct To Consumer. The company offers pants, shorts, tops, and jackets for healthy lifestyle activities and athletic pursuits, such as yoga, running, and general fitness; and dance-inspired apparel for female youth. It also provides fitness-related accessories, counting bags, socks, underwear, yoga mats, and water bottles.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
